Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2016-02-22

FDA Approved: ENTACAPONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for entacapone submitted by Sun Pharmaceutical Industries, Inc. The approval updates the drug’s labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Entacapone (Entacapone)

Snippet

SUPPL AP for ENTACAPONE (ENTACAPONE)